Exposure to chemicals called PFAS during young adulthood has been linked to yet another serious health problem – reduced ...

Breast fat necrosis is harmless, but you'll want to check with your doctor to rule out any chance of breast cancer. Fat necrosis in your breast can show up months or even years after the procedure ...

When multiple myeloma, a cancer that affects a type of white blood cell called a plasma cell, stops responding to treatment, it’s called refractory multiple myeloma. Sometimes treatment works at ...

Polycythemia vera is a slow growing blood cancer that happens in your bone marrow, the spongy tissue inside bones. It's usually caused by a gene mutation. Your bone marrow makes red blood cells ...

Multiple myeloma is a kind of blood cancer that affects white blood cells called plasma cells. Abnormal plasma cells crowd out healthy cells in your bone marrow. And they flood your bloodstream ...

Throat cancer is any cancerous tumor that grows in either your throat or voice box. Your throat (pharynx) is a muscular tube that starts behind your nose and ends in your neck. Your voice box ...

New devices promise to help realign your body’s circadian rhythm for better health, but do they work? Here’s what the experts say.

Memorial Sloan Kettering Cancer Center: “Bone-Related Problems in Multiple Myeloma,” “Pain Management for Multiple Myeloma.” Johns Hopkins Medicine: “Myeloma Bone Disease/Multiple ...

Oct. 24, 2024 – The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer. Marketed under the brand name Vyloy, the drug is to ...

But when your breast cancer is described as HER2-positive, it means the cancer cells have more HER2 protein than usual. Since this protein can make cancer cells grow more quickly, it’s natural ...

Cytogenetic testing should be done (on samples of tissue, blood, or bone marrow) to find gene differences related to specific types of cancer. People with high-risk MM are more likely to relapse ...

The focus of this study was to find out how well Tecvayli worked to manage cancer. To learn this, the researchers looked at the number of people whose cancer shrank (partial response ...